» Articles » PMID: 2601711

A Nuclease-hypersensitive Element of the Human C-myc Promoter Interacts with a Transcription Initiation Factor

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1989 Nov 1
PMID 2601711
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Transcription of the human c-myc oncogene is elaborately regulated, but the relevant molecular mechanisms are not yet understood. To begin to define elements and enzyme systems responsible for c-myc transcription in vitro, we partially purified a transcription factor essential for efficient and accurate in vitro initiation from the principal myc promoter, P2. DNA mobility shift assays located the factor binding domain at -142 to -115 with respect to the P1 promoter. This region contains pur/pyr sequences (predominantly purines in one strand), nuclease-hypersensitive sites (U. Siebenlist, L. Henninghausen, J. Battey, and P. Leder, Cell 37:381-391, 1984; C. Boles and M. Hogan, Biochemistry 26:367-376, 1987), and a triple-helix-forming element (M. Cooney, G. Czernuszewicz, E. Postel, S. Flint, and M. Hogan, Science 241:456-459, 1988). Methylation interference mapping established that the factor, termed PuF, directly contacts the repeated palindromic sequence GGGTGGG of the -142/-115 element. The interaction of PuF with this cis-acting element is necessary for P2 transcription in vitro, for (i) deletion of this 5' region from the myc promoter greatly reduced transcription efficiency and (ii) a synthetic duplex oligonucleotide corresponding to the -142/-115 sequence completely repressed c-myc transcription in the presence of the partially purified factor. These observations lend support to the hypothesis that pur/pyr sequences perform important biological roles in the regulation of c-myc gene expression, most likely by serving as transcription factor binding sites.

Citing Articles

Combining CRISPR activation and interference capabilities using dCas9 and G-quadruplex structures.

Kabir M, Kodikara S, Hoque M, Shiekh S, Alfehaid J, Basu S NAR Mol Med. 2025; 2(1):ugaf001.

PMID: 39906285 PMC: 11788920. DOI: 10.1093/narmme/ugaf001.


Combining the CRISPR Activation and Interference Capabilities Using dCas9 and G-Quadruplex Structures.

Kabir M, Kodikara S, Hoque M, Shiekh S, Alfehaid J, Basu S bioRxiv. 2024; .

PMID: 39605509 PMC: 11601508. DOI: 10.1101/2024.11.19.624357.


Stalling of Transcription by Putative G-quadruplex Sequences and CRISPR-dCas9.

Hoque M, Kabir M, Shiekh S, Balci H, Basu S bioRxiv. 2024; .

PMID: 38559215 PMC: 10979993. DOI: 10.1101/2024.03.17.585391.


Piperine analogs arrest c-myc gene leading to downregulation of transcription for targeting cancer.

Pandya N, Kumar A Sci Rep. 2021; 11(1):22909.

PMID: 34824301 PMC: 8617303. DOI: 10.1038/s41598-021-01529-3.


Evidences for Piperine inhibiting cancer by targeting human G-quadruplex DNA sequences.

Tawani A, Amanullah A, Mishra A, Kumar A Sci Rep. 2016; 6:39239.

PMID: 27995955 PMC: 5171706. DOI: 10.1038/srep39239.


References
1.
Morgan A, Wells R . Specificity of the three-stranded complex formation between double-stranded DNA and single-stranded RNA containing repeating nucleotide sequences. J Mol Biol. 1968; 37(1):63-80. DOI: 10.1016/0022-2836(68)90073-9. View

2.
Elgin S . DNAase I-hypersensitive sites of chromatin. Cell. 1981; 27(3 Pt 2):413-5. DOI: 10.1016/0092-8674(81)90381-0. View

3.
McMaster G, Carmichael G . Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange. Proc Natl Acad Sci U S A. 1977; 74(11):4835-8. PMC: 432050. DOI: 10.1073/pnas.74.11.4835. View

4.
Maxam A, Gilbert W . Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 1980; 65(1):499-560. DOI: 10.1016/s0076-6879(80)65059-9. View

5.
Efstratiadis A, Posakony J, Maniatis T, Lawn R, OConnell C, Spritz R . The structure and evolution of the human beta-globin gene family. Cell. 1980; 21(3):653-68. DOI: 10.1016/0092-8674(80)90429-8. View